Mereo BioPharma Group PLC ADR (MREO) stock news · rev $500.0K
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
This MREO news page leads with what Mereo BioPharma Group PLC ADR filed — not a scraped headline mill.
No cached 8-K sentence for MREO yet. We will not pad this page with generic market recap.
Latest reported MREO revenue for 2025-12-31 was $500.0K. Net income was -$41.9M. MREO currently screens at market cap $48.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MREO stock page; for the tape open the quote page.
MREO stock news FAQ
What are MREO's latest revenue and net income?
Latest cached Mereo BioPharma Group PLC ADR (MREO) revenue for Dec 31, 2025 was $500.0K. Net income was -$41.9M. Statements: https://lician.com/financials/mreo
What is MREO's market cap?
Mereo BioPharma Group PLC ADR (MREO) market cap is $48.7M on the latest cached fundamentals snapshot.
What kind of company is MREO?
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Where is MREO stock news listed?
Cached stock news for Mereo BioPharma Group PLC ADR (MREO) is listed at https://lician.com/news/mreo. Filings: https://lician.com/sec/mreo
Not investment advice.